Balyasny Asset Management’s Definium Therapeutics DFTX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$20.9M Sell
549,443
-348,215
-39% -$14.7M 0.02% 755
2026
Q2
$42.2M Sell
897,658
-376,563
-30% -$9.31M 0.05% 417
2026
Q1
$24.1M Sell
1,274,221
-33,894
-3% -$575K 0.03% 608
2025
Q4
$17.5M Buy
+1,308,115
New +$16.2M 0.02% 784
2025
Q3
– Sell
-38,937
Closed -$253K – 3264
2025
Q2
$253K Sell
38,937
-130,621
-77% -$859K ﹤0.01% 2529
2025
Q1
$992K Buy
+169,558
New +$1.21M ﹤0.01% 1992
2024
Q4
– Sell
-26,386
Closed -$150K – 3073
2024
Q3
$150K Buy
26,386
+8,723
+49% +$60.7K ﹤0.01% 2607
2024
Q2
$127K Buy
+17,663
New +$154K ﹤0.01% 2388
2022
Q3
– Sell
-4,420
Closed -$42K – 3109
2022
Q2
$42K Buy
+4,420
New +$55.9K ﹤0.01% 2388

Other funds holding DFTX

Balyasny Asset Management's DFTX Position: Q3 2026 in Review

Balyasny Asset Management reduced its Definium Therapeutics (DFTX) stake by 39% in Q3 2026, selling an estimated $14.7M and leaving 549,443 shares worth $20.9M. The position accounts for 0.02% of the portfolio, ranked #755.

Balyasny Asset Management first reported a position in DFTX in Q2 2022 and has held it in 9 quarters since. The position peaked at $42.2M in Q2 2026. 354 funds tracked by Wall St. Rank hold DFTX as of Q3 2026.

  • Balyasny Asset Management held 549,443 shares of Definium Therapeutics worth $20.9M as of Q3 2026.
  • Balyasny Asset Management sold 348,215 Definium Therapeutics shares in Q3 2026, an estimated $14.7M.
  • Definium Therapeutics made up 0.02% of Balyasny Asset Management's portfolio in Q3 2026, its #755 holding.
  • Balyasny Asset Management first reported a position in Definium Therapeutics in Q2 2022 and has held it in 9 quarters since.
  • Balyasny Asset Management's Definium Therapeutics position peaked at $42.2M in Q2 2026.
  • 354 funds tracked by Wall St. Rank held Definium Therapeutics as of Q3 2026.

Based on Balyasny Asset Management's 13F filing for Q3 2026, filed 16 Nov 2026.